Esperion Therapeutics Inc (ESPR)
2.165
+0.20
(+10.46%)
USD |
NASDAQ |
Oct 04, 16:00
2.17
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics Shareholders Equity (Annual): -454.99M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -454.99M |
| December 31, 2022 | -323.78M |
| December 31, 2021 | -196.94M |
| December 31, 2020 | -96.13M |
| December 31, 2019 | 19.95M |
| December 31, 2018 | 79.12M |
| December 31, 2017 | 244.69M |
| December 31, 2016 | 228.60M |
| December 31, 2015 | 287.26M |
| Date | Value |
|---|---|
| December 31, 2014 | 133.55M |
| December 31, 2013 | 74.09M |
| December 31, 2012 | -17.39M |
| December 31, 2011 | -6.057M |
| December 31, 2002 | 38.74M |
| December 31, 2001 | 66.50M |
| December 31, 2000 | 67.69M |
| December 31, 1999 | 2.815M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-454.99M
Minimum
2023
19.95M
Maximum
2019
-210.38M
Average
-196.94M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Perspective Therapeutics Inc | 75.18M |
| Nektar Therapeutics | 130.99M |
| Alaunos Therapeutics Inc | 6.307M |
| Oragenics Inc | 3.168M |
| Cocrystal Pharma Inc | 26.38M |